Global Market Insights, Inc. - logo

Vocal Biomarkers Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Italy, France, Spain, Italy, Russia, Poland, China, India, Japan, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Qatar, Kuwait, Egypt, UAE), Application Development Potential, Competitive Market Share & Forecast, 2017 – 2024

Report ID: GMI1852

Inquiry Before Buying   Table of Contents

Vocal Biomarkers Market size is projected to experience significant growth from 2017 to 2024.
 

Vocal biomarkers market size witness significant growth due to increased prevalence of cardiovascular and psychological diseases over the last few years. Growing demand for minimally invasive procedures from patients coupled with fast recovery should fuel the global vocal biomarkers market size during the forecast period.
 

Sound vibrations are used as therapeutic healing for mental health conditions which includes depression, nervousness, and coronary artery disease. Ongoing research has significantly widened its application in disease diagnosis. Health Insurance Portability and Accountability Act (HIPAA) compliant vocal biomarker system may serve as effective technique due to the successful completion of clinical trials. It serves as an alternative to existing diagnostic technique such as CT scan, MRI and X-Ray. High cost associated with these tests may result into burden for governments and insurance companies eventually leading to hamper the business growth.
 

Continuous research to identify vocal biomarkers in diagnosis of Parkinson’s disease, cognitive impairment, respiratory diseases, and traumatic brain injury will provide highly lucrative growth opportunities for industry players. The technology is user-friendly and offers self-diagnosis and medication. As per the WHO 2016 data, nearly 350 million individuals were suffering from depression. According to the Parkinson’s disease Foundation 2016, around 10 million individuals were suffering with Parkinson’s disease across the world. Growing global disease prevalence will drive vocal biomarkers market size in the coming years.   
 

Growing prevalence of respiratory diseases such as asthma should drive industry growth. As per European Respiratory Society, over 235 million people suffer from asthma across the world in 2016. Psychiatric and medical diagnosis can be more precise when access to huge amount of biological and psychological data and speech feature is recorded. Mayo Clinic in Minnesota is tracking vocal biomarkers to enhance remote health monitoring of patients with heart disease. Clinic is working with Israeli company Beyond Verbal to test the voice of patients with coronary artery disease. Health insurers will contribute for lucrative growth. Humana, Blue Cross Blue Shield Association, and Aetna are using vocal biomarkers to identify stress and depression among callers.  
 

U.S. vocal biomarker market size should experience significant growth over the forecast period. The growth is attributed due to the robust healthcare infrastructure and home for several well-funded research based organizations with leading technology. U.S. government agencies are associated with voice-based analysis researchers and firms for the product application in various fields such as trauma, geriatrics, and the country is also engaged in research related to innovative voice-analysis products particularly for self-diagnosis. These factors should provide lucrative growth opportunities for vocal biomarkers market growth over the forecast period.
 

In May 2016, the U.S. Army entered into collaboration with MIT researchers to develop voice-based detection technology for diagnosis of brain injury. American Heart Association in collaboration with Beyond Verbal and Mayo Clinic has developed artificial intelligence (AI) algorithms by using machine-learning to perceive voice patterns imperceptible to human ear for initial identification of coronary heart disease.
 

Companies operating in vocal biomarkers market include Beyond Verbal, Sonde Health, IBM, Cogito and Sharecare. Companies are majorly focusing on collaboration with university and industry players. For instance, Beyond Verbal is working with Scripps, Mayo Clinic, Tel Aviv University and Hadassah Medical Center in Jerusalem for the expansion of vocal biomarker research in healthcare sector.   
 


What Information does this report contain?

What was the historic market data from 2013 to 2016, what is the industry growth forecast from 2017 to 2024?
A detailed analysis of regulatory trends, growth drivers, industry pitfalls, challenges and opportunities for participants
Which are the leading market products, applications & regions and how will they perform by 2024?
What are the technology & innovation trends, how will they evolve by 2024?
Which companies lead the industry, how are they positioned in the market in terms of sustainability, competency, production capacity and strategic outlook?

Why Global Market Insights?

 Comprehensive Research
  • All-inclusive coverage
  • In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
  • Penetrative insights & latest trends
  • Offers holistic understanding of the market
 Data Accuracy & Reliability
  • Unique methodology
  • Iterative in nature to eliminate errors
  • Detailed methodology, scope, assumptions and data sources available for reference
 Post-Sales Support
  • Committed to making a positive difference for our clients
  • Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
  • Every purchase comes with an option to obtain additional information:
    • up to 10% of the original cost
    • 45-minute analyst tele-call to obtain further clarity on the market.
 Security & Confidentiality
  • Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
  • Only PCI-DSS compliant payment methods used for highest level of client data security

Connect with our sales team